US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ITT Inc.

159.20

+1.530.97%

Volume:353.20K

Turnover:56.16M

Market Cap:12.53B

PE:25.34

High:159.72

Open:157.89

Low:157.89

Close:157.67

Loading ...

Overview Company News Filings

Investors in ITT (NYSE:ITT) have seen splendid returns of 132% over the past five years

Simply Wall St.

LXU or ITT: Which Is the Better Value Stock Right Now?

ITT (ITT) Reports Next Week: Wall Street Expects Earnings Growth

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at the Harvard Club, New York City

ITT Announces Participation at Upcoming Investor Conferences in February

IMNN: Gearing Up to Initiate Phase 3 Ovarian Cancer Trial in 1Q25…

Zacks Small Cap Research

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why

Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to MASH—by Both Completer and ITT Analyses—at Week 96 in Phase 2b SYMMETRY Study

Press Release: ITT Updates Call Time for 2024 Fourth Quarter and Full Year Results and 2025 Outlook on Feb. 6

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

ITT price target raised to $170 from $164 at KeyBanc

KeyBanc Remains a Buy on ITT (ITT)

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

ITT Benefits From Strength Across Segments Despite High Costs

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ITT/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ITT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ITT\",,,,,undefined,":{"symbol":"ITT","market":"US","secType":"STK","nameCN":"ITT Inc.","latestPrice":159.2,"timestamp":1752782400000,"preClose":157.67,"halted":0,"volume":353195,"delay":0,"floatShares":73476806,"shares":78700000,"eps":6.281608,"marketStatus":"Pre-Mkt","change":1.53,"latestTime":"07-18 05:24:22 EDT","open":157.89,"high":159.72,"low":157.89,"amount":56157584.69795,"amplitude":0.011607,"askPrice":253.12,"askSize":100,"bidPrice":141.8,"bidSize":6,"shortable":3,"etf":0,"ttmEps":6.281608,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1752845400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-264888000000,"exchange":"NYSE","adjPreClose":159.2,"dividendRate":0.008417,"postHourTrading":{"tag":"盘后","latestPrice":159.2,"preClose":159.2,"latestTime":"19:04 EDT","volume":16660,"amount":2652254.52,"timestamp":1752793477707},"volumeRatio":0.9464036416638919,"impliedVol":0.2515,"impliedVolPercentile":0.1446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ITT\",,,,,undefined,":{"symbol":"ITT","floatShares":73476806,"roa":"8.58%","roe":"19.30%","lyrEps":6.336185,"volumeRatio":0.9464036416638919,"shares":78700000,"dividePrice":1.34,"high":159.72,"amplitude":0.011607,"preClose":157.67,"low":157.89,"week52Low":105.64,"pbRate":"4.51","psRate":"3.45","week52High":161.79,"institutionHeld":0.8576,"latestPrice":159.2,"committee":-0.886792,"eps":6.281608,"divideRate":0.008417,"volume":353195,"delay":0,"ttmEps":6.281608,"open":157.89,"prevYearClose":142.88,"prevWeekClose":157.86,"prevMonthClose":156.83,"prevQuarterClose":156.83,"fiveDayClose":157.56,"twentyDayClose":149.82,"sixtyDayClose":125.4,"earningDate":1753891200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ITT\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508541138","title":"Investors in ITT (NYSE:ITT) have seen splendid returns of 132% over the past five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2508541138","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508541138?lang=en_us&edition=fundamental","pubTime":"2025-02-02 20:23","pubTimestamp":1738499011,"startTime":"0","endTime":"0","summary":"The most you can lose on any stock  is 100% of your money. But on the bright side, you can make far more than 100% on a really good stock. For instance, the price of ITT Inc.  stock is up an impressive 119% over the last five years.With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.During five years of share price growth, ITT achieved compound earnings per share  growth of 11% per year. This EPS growth is lower than the 17% average annual increase in the share price. So it's fair to assume the market has a higher opinion of the business than it did five years ago. And that's hardly shocking given the track record of growth.The graphic below depicts how EPS has changed over time .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-itt-nyse-itt-seen-122331145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","NYSE","ISBC","LU0053671581.USD","BK4161","LU0054578231.USD","ITT"],"gpt_icon":0},{"id":"2508995418","title":"LXU or ITT: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2508995418","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508995418?lang=en_us&edition=fundamental","pubTime":"2025-02-01 00:40","pubTimestamp":1738341611,"startTime":"0","endTime":"0","summary":"Investors looking for stocks in the Diversified Operations sector might want to consider either LSB  or ITT . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.LSB and ITT are sporting Zacks Ranks of #2  and #3 , respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that LXU has an improving earnings outlook. But this is just one factor that value investors are interested in.LXU currently has a forward P/E ratio of 17.13, while ITT has a forward P/E of 23.44. We also note that LXU has a PEG ratio of 0.80. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. ITT currently has a PEG ratio of 1.82.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lxu-itt-better-value-stock-164011534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITT","BK4161","LU0053671581.USD","LU0054578231.USD","BK4098","LXU"],"gpt_icon":0},{"id":"2507675394","title":"ITT (ITT) Reports Next Week: Wall Street Expects Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2507675394","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507675394?lang=en_us&edition=fundamental","pubTime":"2025-01-30 23:01","pubTimestamp":1738249274,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on higher revenues when ITT  reports results for the quarter ended December 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 6. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This supplier of parts and services to a wide variety of industries is expected to post quarterly earnings of $1.46 per share in its upcoming report, which represents a year-over-year change of +9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/itt-itt-reports-next-week-150114866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITT"],"gpt_icon":0},{"id":"2507640702","title":"Gabelli Funds to Host Pump, Valve & Water Systems Symposium at the Harvard Club, New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2507640702","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507640702?lang=en_us&edition=fundamental","pubTime":"2025-01-30 21:00","pubTimestamp":1738242000,"startTime":"0","endTime":"0","summary":"GREENWICH, Conn., Jan. 30, 2025  -- Gabelli Funds is hosting its 35th annual Pump, Valve & Water Systems Symposium at the Harvard Club in New York City on Thursday, February 27, 2025. The symposium focuses on themes crucial to this industry, including infrastructure spending, resource security, conservation, and mergers and acquisitions (M&A). Attendees will have the opportunity to engage in one-on-one sessions with management, providing an opportunity to delve into the strategies and growth prospects of these companies.This symposium underscores the pivotal role of the pump, valve, and water systems industry in addressing global challenges. It highlights the sector's significance in infrastructure development, resource management, and environmental sustainability. With a focus on key themes and direct interactions with management, the event aims to offer investors valuable insights into industry trends and potential investment opportunities within this dynamic and vital sector.Registr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gabelli-funds-host-pump-valve-130000397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GGG","LU1721427968.SGD","MWA","LU1165135440.EUR","NPO","BK4161","BK4135","BK4585","IE00B19Z6F94.USD","BK4086","LU0323239441.USD","LU0566484027.USD","BK4096","BMI","ROCK","AME","WTS","BK4181","GRC","HST","LU1559883803.SGD","EPAC","FELE","CR","GGZ","IE0034390439.USD","LU2065732104.USD","LU2229751404.USD","LU1543694498.USD","LU0054578231.USD","BK4588","LU0323240290.USD","BK4211","FLS","LU2089279066.USD","ITT","GAMI","CHCO","IE00BQXX3D17.EUR","LU0053671581.USD","BK4218","IE00BQXX3F31.USD","BK4157","GHM","IE00BQXX3C00.GBP"],"gpt_icon":0},{"id":"2507842176","title":"ITT Announces Participation at Upcoming Investor Conferences in February","url":"https://stock-news.laohu8.com/highlight/detail?id=2507842176","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507842176?lang=en_us&edition=fundamental","pubTime":"2025-01-29 19:30","pubTimestamp":1738150200,"startTime":"0","endTime":"0","summary":"STAMFORD, Conn., January 29, 2025----January 29, 2025-- ITT Inc.  today announced its participation at investor conferences hosted by TD Cowen, Citi and Gabelli in February 2025.Chief Financial Officer Emmanuel Caprais will present at the TD Cowen 46th Annual Aerospace & Defense Conference in Washington D.C. on Feb. 12 at 3:35 p.m. Eastern Time.Chief Executive Officer and President Luca Savi will present at the Citi 2025 Global Industrial Tech and Mobility Conference in Miami on Feb. 20 at 8 a.m. Eastern Time.Additionally, Caprais will also present at the Gabelli 35th Annual Pump, Valve & Water Systems Symposium on Feb. 27 in New York at 10 a.m. Eastern Time.ITT is a diversified leading manufacturer of highly engineered critical components and customized technology solutions for the transportation, industrial, and energy markets. Building on its heritage of innovation, ITT partners with its customers to deliver enduring solutions to the key industries that underpin our modern way of li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/itt-announces-participation-upcoming-investor-113000101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0054578231.USD","LU0053671581.USD","BK4161","ITT"],"gpt_icon":0},{"id":"2507472975","title":"IMNN: Gearing Up to Initiate Phase 3 Ovarian Cancer Trial in 1Q25…","url":"https://stock-news.laohu8.com/highlight/detail?id=2507472975","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507472975?lang=en_us&edition=fundamental","pubTime":"2025-01-28 22:10","pubTimestamp":1738073400,"startTime":"0","endTime":"0","summary":"Imunon, Inc.  is continuing preparations to conduct a Phase 3 clinical trial of its lead development compound, IMNN-001, in patients with advanced ovarian cancer. IMNN-001 is a DNA immunotherapeutic drug that consists of an interleukin -12 expressing plasmid that allows for the durable, local, and targeted expression of IL-12 in the peritoneum. IL-12 is a potent pro-inflammatory cytokine that mediates a number of important cellular processes, including T cell and natural killer cell activation , the production of interferon-gamma , and alteration of myeloid-derived suppressor cells in the tumor microenvironment . While shown to be effective in pre-clinical tumor models, IL-12 therapy initially showed underwhelming results in the clinic along with very high levels of toxicity when administered systemically. This is likely due to the fact that the direct targets of IL-12 are not circulating lymphocytes, but rather immune cells located within the tumor and lymph nodes. Thus, while systemi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imnn-gearing-initiate-phase-3-141000805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IMNN","IE00B1BXHZ80.USD","BK4097","IE00BZ1G4Q59.USD","BK4113","LU0170899867.USD","IE00BHPRN162.USD","LU0882574139.USD","IE00BKVL7J92.USD","BK4006","LU0267386448.USD","OS","LU0054578231.USD","BK4139","BK4161","LU0971096721.USD","LU1363072403.SGD","HR","CBD","BK4225","ITT","CMC","LU0053671581.USD","LU0149725797.USD","BK4203"],"gpt_icon":0},{"id":"2506519597","title":"Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2506519597","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506519597?lang=en_us&edition=fundamental","pubTime":"2025-01-28 20:00","pubTimestamp":1738065600,"startTime":"0","endTime":"0","summary":"35% objective response rate  in second-line colorectal cancer  patients treated with sirexatamab  plus bevacizumab and chemotherapy, compared to 23% ORR in the control arm. DKK1 levels highly correlated with clinical activity in CRC population. ORR benefit with sirexatamab observed across multiple potential Phase 3 CRC populations. Preparations will begin for a registrational Phase 3 study in second-line CRC patients. DisTinGuish Part C study in gastric cancer demonstrates activity in biomarker populations,but not the signal necessary to advance into Phase 3. CAMBRIDGE, Mass., Jan. 28, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data from Part B of the DeFianCe study evaluating sirexatamab  in combination with bevacizumab and chemotherapy as a second-line treatment for patients with advanced colorectal cancer , and initial data from Part C of the DisTinGuish stud","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/leap-therapeutics-reports-initial-clinical-120000712.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/leap-therapeutics-reports-initial-clinical-120000712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","MSS","IE00BMPRXR70.SGD","LU0054578231.USD","BK4505","CRC","BK4211","LU0266512127.USD","BK4113","LU0456854461.SGD","BK4563","LU0348723411.USD","ITT","PFS","LENZ","BK4195","LPTX","BK4139","BK4588","BK4543","LU0053671581.USD","BK4161","ORR","IE00BMPRXQ63.HKD","BK4141","IE00BMPRXN33.USD","BK4585"],"gpt_icon":1},{"id":"2506469370","title":"Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2506469370","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506469370?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:01","pubTimestamp":1737986519,"startTime":"0","endTime":"0","summary":"On Monday, Akero Therapeutics, Inc. released preliminary topline week 96 results from SYMMETRY Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin  in patients with biopsy-confirmed compensated cirrhosis , Child-Pugh Class A, due to metabolic dysfunction-associated steatohepatitis .Among patients with baseline and week 96 biopsies , 39% of patients treated with 50mg EFX  experienced reversal of cirrhosis with no worsening of MASH, representing a 24% effect size over placebo at 15% .In the Intent to Treat  population , with all missing week 96 biopsies treated as failures, 29% of patients in the 50mg EFX group  experienced reversal of cirrhosis with no worsening of MASH, representing a 17% effect size over placebo at 12% .With more than a doubling of effect size from weeks 36 to 96 in the 50mg group , the SYMMETRY study underscores the benefit of longer EFX treatment for patients with compensated cirrhosis .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liver-disease-focused-akero-therapeutics-140159595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0054578231.USD","AKRO","BK4585","BK4123","BK4139","BK4505","EFX","LU0053671581.USD","ITT","BK4588","BK4161"],"gpt_icon":0},{"id":"2506929373","title":"Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to MASH—by Both Completer and ITT Analyses—at Week 96 in Phase 2b SYMMETRY Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2506929373","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506929373?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:30","pubTimestamp":1737977400,"startTime":"0","endTime":"0","summary":"Among patients with baseline and week 96 biopsies, 39% of the 50mg EFX group (p=0.009) demonstrated ≥1 stage improvement in fibrosis with no worsening of MASH, representing a 24% effect size over plac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/27/3015438/0/en/Akero-Therapeutics-Reports-Preliminary-Topline-Results-Showing-Statistically-Significant-Reversal-of-Compensated-Cirrhosis-F4-Due-to-MASH-by-Both-Completer-and-ITT-Analyses-at-Week.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","EFX","LU0053671581.USD","LU0054578231.USD","BK4161","BK4588","ITT","BK4585","BK4139","AKRO","BK4505"],"gpt_icon":0},{"id":"2505099830","title":"Press Release: ITT Updates Call Time for 2024 Fourth Quarter and Full Year Results and 2025 Outlook on Feb. 6","url":"https://stock-news.laohu8.com/highlight/detail?id=2505099830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505099830?lang=en_us&edition=fundamental","pubTime":"2025-01-23 19:32","pubTimestamp":1737631920,"startTime":"0","endTime":"0","summary":"Jan. 23, 2025-- ITT Inc.  today updated its investor conference call time on Thursday, Feb. 6, 2025 to 9:30 a.m. Eastern Time . ITT is making this change to better accommodate investors and analysts that may be impacted by conflicting call times from peer companies. During the call, ITT will discuss its 2024 fourth quarter and full year financial results and 2025 outlook.To participate on the conference call, click here to register. After completing the online registration form, participants will receive the dial-in number and a unique PIN. Participants should join the call ten minutes before 9:30 a.m. Eastern Time on Thursday, Feb. 6. All dial-in information for participants who previously registered for the call is still valid and no action is required due to this scheduling change.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","ITT","LU0054578231.USD","BK4161"],"gpt_icon":0},{"id":"2505145229","title":"RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published","url":"https://stock-news.laohu8.com/highlight/detail?id=2505145229","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505145229?lang=en_us&edition=fundamental","pubTime":"2025-01-21 20:00","pubTimestamp":1737460800,"startTime":"0","endTime":"0","summary":"Talicia is now covered by Humana's Part D Plan, providing access to Talicia for H. pylori therapy to more than eight million additional Medicare lives, without requiring prior therapeutic steps or authorization. Additionally, new data describing the foundations for Talicia's recent FDA-approved label change to a more convenient three-times daily  \"breakfast, lunch, and dinner\" dosing routine, supporting patient adherence, has been published in the Journal of Clinical Pharmacology. The published data describe the use of physiologically-based pharmacokinetic  modeling and simulation to demonstrate pharmacokinetic equivalence of the TID regimen to the previous every 8-hour  dosing regimen. H. pylori infection affects approximately 35% of the U.S. adult population and is classified by the World Health Organization  as a Group 1 carcinogen, being the strongest known risk factor for gastric cancer and a major risk factor for peptic ulcer disease. The result of a successful collaboration with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/redhills-talicia-adds-8-million-120000783.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/redhills-talicia-adds-8-million-120000783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TEN","BK4548","LU0053671581.USD","BK4144","BK4161","BK4121","BK4124","BNTX","SEER","LU0054578231.USD","BK4007","BK4585","BK4535","PPI","BK4568","SLE","BK4551","BK4139","BK4570","BK4588","BK4077","RDHL","ITT"],"gpt_icon":0},{"id":"2505223210","title":"ITT price target raised to $170 from $164 at KeyBanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2505223210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505223210?lang=en_us&edition=fundamental","pubTime":"2025-01-21 19:25","pubTimestamp":1737458744,"startTime":"0","endTime":"0","summary":"KeyBanc analyst Jeffrey Hammond raised the firm’s price target on ITT (ITT) to $170 from $164 and keeps an Overweight rating on the shares ahead of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/itt-price-target-raised-to-170-from-164-at-keybanc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/itt-price-target-raised-to-170-from-164-at-keybanc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITT"],"gpt_icon":0},{"id":"2505245019","title":"KeyBanc Remains a Buy on ITT (ITT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505245019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505245019?lang=en_us&edition=fundamental","pubTime":"2025-01-21 17:15","pubTimestamp":1737450906,"startTime":"0","endTime":"0","summary":"In a report released today, Jeffrey Hammond from KeyBanc maintained a Buy rating on ITT (ITT – Research Report), with a price target of $170.00. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/keybanc-remains-a-buy-on-itt-itt-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/keybanc-remains-a-buy-on-itt-itt-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ITT","LU0054578231.USD","LU0053671581.USD","BK4161"],"gpt_icon":0},{"id":"2504948330","title":"Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2504948330","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504948330?lang=en_us&edition=fundamental","pubTime":"2025-01-17 01:09","pubTimestamp":1737047390,"startTime":"0","endTime":"0","summary":"On Thursday, Outlook Therapeutics, Inc.  completed the analysis of the complete 12-week safety and efficacy results for NORSE EIGHT evaluating ONS-5010 in wet age-related macular degeneration  patients.ONS-5010 demonstrated non-inferiority to Novartis AG  / Roche Holdings AG’s  Lucentis  at week 12 in the NORSE EIGHT trial. Based on the completed analysis of the 12-week results, Outlook Therapeutics plans to resubmit the Biologics License Application  for ONS-5010 in the first quarter of calendar 2025.The difference in the mean between ONS-5010 and ranibizumab was -1.009 best corrected visual acuity  letters.In the intent-to-treat  population, NORSE EIGHT demonstrated a mean 5.5 letter improvement in BCVA in the ONS-5010 arm and 6.5 letter improvement in BCVA in the ranibizumab arm.As previously announced, in the NORSE EIGHT trial, ONS-5010 did not meet the pre-specified non-inferiority endpoint at week 8 outlined in the special protocol assessment  with the U.S. Food and Drug Administ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/outlook-therapeutics-vision-loss-drug-170950455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","BK4139","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4161","NVS","LU0054578231.USD","BK4585","SPA","BK4007","LENZ","LU0211331839.USD","BK4532","IE0009355771.USD","ITT","BK4578","OTLK","LU0053671581.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2504911776","title":"ITT Benefits From Strength Across Segments Despite High Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2504911776","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504911776?lang=en_us&edition=fundamental","pubTime":"2025-01-16 22:04","pubTimestamp":1737036240,"startTime":"0","endTime":"0","summary":"The company’s costs and expenses have been rising over the last several quarters, resulting in the contraction of margins. In the first nine months of 2024, the cost of sales increased 8.5% year over year due to rising raw material and labor costs. Sales and marketing expenses rose 15% year over year in the same period while general and administrative expenses increased 5.7%. If not checked, high raw material costs may affect margins and profitability in 2024.ITT intends to become more competent on the back of overseas business expansion. It has operations in the United States and Canada; Europe, the Middle East, and Africa; the Asia Pacific and Latin America. However, this exposes the company to several economic, political and environmental headwinds as well as movement in f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/itt-benefits-strength-across-segments-140400627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","LU2065731478.USD","GHC","GHM","ITT","BK4588","BK4096","BK4006","GNRC","BK4561","LU0054578231.USD","BK4136","LU0823414478.USD","LU1878469433.USD","BK4585","BK4104","LU2463526074.USD","LU2249611893.SGD","IP","MT","AIT","LU0053671581.USD","CCT"],"gpt_icon":0},{"id":"2503962817","title":"Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2503962817","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503962817?lang=en_us&edition=fundamental","pubTime":"2025-01-16 19:00","pubTimestamp":1737025200,"startTime":"0","endTime":"0","summary":"ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks. Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in gross proceeds. Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital and an Outlook Therapeutics Board member, commented, “The 3-month data from NORSE EIGHT provides additional evidence to confirm what retina specialists expected. The clinical trial continues to demonstrate that ONS-5010 injections result in immediate and sustained anatomic efficacy, with steady gains in visual acuity and reliable, consistent safety.”As previously announced, in the NORSE EIGHT trial, ONS-5010 did not meet the pre-specified non-inferiority endpoint at week 8 set forth in the special protocol assessment  with the U.S. Food and Drug Administration . However, BCVA data across all study timepoints demonstrated an im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/outlook-therapeutics-announces-complete-twelve-110000275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823421416.USD","LU0889565833.HKD","LU1988902786.USD","LU0390134368.USD","LU0642271901.SGD","LU1242518931.SGD","ITT","LU0823421333.USD","BK4512","LU0979878070.USD","BK4543","LU0082616367.USD","LU2458330169.SGD","BK4566","LU0081259029.USD","IE0009356076.USD","BK4532","LU0719512351.SGD","IE00BMPRXN33.USD","LU2360106780.USD","LU0053671581.USD","BK4575","LU1951198990.SGD","BK4529","UK","LU1923623000.USD","BK4205","LU2054465674.USD","GFS","OTLK","LENZ","LU0198837287.USD","LU1303367103.USD","BK4141","BK4534","LU1951200564.SGD","LU0127658192.USD","LU2098885051.SGD","LU1880398471.USD","LU0109392836.USD","BK4139","IE00B5949003.HKD","IE00BMPRXR70.SGD","SPA","LU0056508442.USD","LU2250418816.HKD","LU0823434740.USD","LU0054578231.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":136,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ITT\",params:#limit:5,,,undefined,":[{"date":"2025-07-31","symbol":"ITT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":1.62,"defaultRemindTime":1753948800000,"name":null,"time":"Pre-Market","dateTimestamp":1753934400000,"actualEps":null},{"date":"2025-06-02","symbol":"ITT","amount":0.351,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-02","defaultRemindTime":1748871000000,"name":"ITT Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-02","currency":"USD","dateTimestamp":1748836800000,"payDate":"2025-06-30"},{"market":"US","date":"2025-05-01","symbol":"ITT","fiscalQuarterEnding":"2025/03","expectedEps":1.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":1.45},{"date":"2025-04-10","symbol":"ITT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1744272000000,"name":null,"time":"Pre-Market","dateTimestamp":1744257600000,"actualEps":null},{"date":"2025-03-06","symbol":"ITT","amount":0.351,"announcedDate":"2025-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-06","defaultRemindTime":1741271400000,"name":"ITT Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-06","currency":"USD","dateTimestamp":1741237200000,"payDate":"2025-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ITT\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-09","recordDate":"2015-09-11","paymentDate":"2015-10-01","value":0.1183,"currency":"USD"},{"executeDate":"2015-12-09","recordDate":"2015-12-11","paymentDate":"2015-12-31","value":0.1183,"currency":"USD"},{"executeDate":"2016-03-09","recordDate":"2016-03-11","paymentDate":"2016-04-01","value":0.124,"currency":"USD"},{"executeDate":"2016-06-08","recordDate":"2016-06-10","paymentDate":"2016-07-01","value":0.124,"currency":"USD"},{"executeDate":"2016-09-07","recordDate":"2016-09-09","paymentDate":"2016-10-03","value":0.124,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ITT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":14,"updateTime":1751169600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ITT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ITT","date":"2025-07-16","current":23.819276,"percent":0.536007,"low":14.994179,"twenty":18.834814,"median":22.99592,"eighty":43.147292,"high":131.975778,"avg":37.144047,"sd":32.524948,"marketCap":12271691000},"quantilePoints":[{"date":"2020-07-17","current":15.345904,"twenty":10.52067,"median":17.126543,"eighty":22.629291,"marketCap":5196123000},{"date":"2020-07-24","current":15.154749,"twenty":10.568558,"median":17.126543,"eighty":22.629291,"marketCap":5131398000},{"date":"2020-07-31","current":15.596848,"twenty":10.589824,"median":17.126543,"eighty":22.629291,"marketCap":4987872000},{"date":"2020-08-07","current":16.30469,"twenty":10.604384,"median":17.126543,"eighty":22.629291,"marketCap":5214240000},{"date":"2020-08-14","current":16.920675,"twenty":10.62804,"median":17.126543,"eighty":22.629291,"marketCap":5411232000},{"date":"2020-08-21","current":16.466792,"twenty":10.650707,"median":17.126543,"eighty":22.629291,"marketCap":5266080000},{"date":"2020-08-28","current":17.301614,"twenty":10.656266,"median":17.12963,"eighty":22.629291,"marketCap":5533056000},{"date":"2020-09-04","current":17.009831,"twenty":10.667871,"median":17.170741,"eighty":22.629291,"marketCap":5439744000},{"date":"2020-09-11","current":16.915272,"twenty":10.678183,"median":17.170741,"eighty":22.629291,"marketCap":5409504000},{"date":"2020-09-18","current":16.801801,"twenty":10.70783,"median":17.191176,"eighty":22.629291,"marketCap":5373216000},{"date":"2020-09-25","current":15.750844,"twenty":10.717391,"median":17.191176,"eighty":22.629291,"marketCap":5037120000},{"date":"2020-10-02","current":15.929156,"twenty":10.743538,"median":17.191176,"eighty":22.629291,"marketCap":5094144000},{"date":"2020-10-09","current":17.358349,"twenty":10.767267,"median":17.196248,"eighty":22.629291,"marketCap":5551200000},{"date":"2020-10-16","current":17.469118,"twenty":10.801244,"median":17.214815,"eighty":22.629291,"marketCap":5586624000},{"date":"2020-10-23","current":17.914897,"twenty":10.850488,"median":17.277298,"eighty":22.629291,"marketCap":5729184000},{"date":"2020-10-30","current":33.860518,"twenty":10.889523,"median":17.301614,"eighty":22.658402,"marketCap":5228064000},{"date":"2020-11-06","current":36.233161,"twenty":10.889523,"median":17.301614,"eighty":22.762071,"marketCap":5594400000},{"date":"2020-11-13","current":38.924767,"twenty":10.889523,"median":17.301614,"eighty":22.839005,"marketCap":6009984000},{"date":"2020-11-20","current":40.250984,"twenty":10.889523,"median":17.301614,"eighty":22.929598,"marketCap":6214752000},{"date":"2020-11-27","current":41.974508,"twenty":10.889523,"median":17.301614,"eighty":23.009543,"marketCap":6480864000},{"date":"2020-12-04","current":42.785907,"twenty":10.889523,"median":17.301614,"eighty":23.079407,"marketCap":6606144000},{"date":"2020-12-11","current":43.474197,"twenty":10.889523,"median":17.301614,"eighty":23.179457,"marketCap":6712416000},{"date":"2020-12-18","current":43.351088,"twenty":10.889523,"median":17.301614,"eighty":23.242214,"marketCap":6693408000},{"date":"2020-12-24","current":42.802694,"twenty":10.889523,"median":17.301614,"eighty":23.327458,"marketCap":6608736000},{"date":"2020-12-31","current":43.099275,"twenty":10.889523,"median":17.301614,"eighty":23.412467,"marketCap":6654528000},{"date":"2021-01-08","current":45.550259,"twenty":10.889523,"median":17.301614,"eighty":23.526044,"marketCap":7032960000},{"date":"2021-01-15","current":45.298446,"twenty":10.889523,"median":17.301614,"eighty":23.717117,"marketCap":6994080000},{"date":"2021-01-22","current":44.884352,"twenty":10.889523,"median":17.316932,"eighty":23.845206,"marketCap":6930144000},{"date":"2021-01-29","current":41.806632,"twenty":10.889523,"median":17.340741,"eighty":23.936,"marketCap":6454944000},{"date":"2021-02-05","current":44.078549,"twenty":10.889523,"median":17.340741,"eighty":24.037389,"marketCap":6805728000},{"date":"2021-02-12","current":44.257617,"twenty":10.889523,"median":17.358349,"eighty":24.073583,"marketCap":6833376000},{"date":"2021-02-19","current":93.53931,"twenty":10.889523,"median":17.358349,"eighty":24.212925,"marketCap":6781600000},{"date":"2021-02-26","current":99.003724,"twenty":10.889523,"median":17.358349,"eighty":24.261242,"marketCap":7177770000},{"date":"2021-03-05","current":103.859655,"twenty":10.885319,"median":17.350244,"eighty":25.094663,"marketCap":7529825000},{"date":"2021-03-12","current":106.317448,"twenty":10.885319,"median":17.350244,"eighty":26.735615,"marketCap":7708015000},{"date":"2021-03-19","current":105.231724,"twenty":10.885319,"median":17.350244,"eighty":26.790358,"marketCap":7629300000},{"date":"2021-03-26","current":108.214483,"twenty":10.889523,"median":17.358349,"eighty":26.882764,"marketCap":7845550000},{"date":"2021-04-01","current":108.369586,"twenty":10.889523,"median":17.358349,"eighty":27.019998,"marketCap":7856795000},{"date":"2021-04-09","current":108.427987,"twenty":10.885319,"median":17.350244,"eighty":27.105561,"marketCap":7861029063},{"date":"2021-04-16","current":110.077849,"twenty":10.885319,"median":17.350244,"eighty":27.179899,"marketCap":7980644064},{"date":"2021-04-23","current":112.036319,"twenty":10.885319,"median":17.350244,"eighty":27.286907,"marketCap":8122633095},{"date":"2021-04-30","current":111.941362,"twenty":10.885319,"median":17.350244,"eighty":27.404005,"marketCap":8115748778},{"date":"2021-05-07","current":115.235449,"twenty":10.885319,"median":17.361784,"eighty":27.486643,"marketCap":8515899683},{"date":"2021-05-14","current":112.05646,"twenty":10.885319,"median":17.38964,"eighty":27.561853,"marketCap":8280972378},{"date":"2021-05-21","current":107.689716,"twenty":10.893727,"median":17.409413,"eighty":27.614282,"marketCap":7958270035},{"date":"2021-05-28","current":109.343257,"twenty":10.902735,"median":17.438894,"eighty":27.661932,"marketCap":8080466656},{"date":"2021-06-04","current":109.890555,"twenty":10.909728,"median":17.44371,"eighty":27.73234,"marketCap":8120912016},{"date":"2021-06-11","current":108.481552,"twenty":10.909728,"median":17.516343,"eighty":27.858925,"marketCap":8016786727},{"date":"2021-06-18","current":101.552986,"twenty":10.909728,"median":17.585632,"eighty":27.955817,"marketCap":7504765677},{"date":"2021-06-25","current":106.57183,"twenty":10.909728,"median":17.65972,"eighty":28.018394,"marketCap":7875658236},{"date":"2021-07-02","current":109.319967,"twenty":10.909728,"median":17.711147,"eighty":28.042944,"marketCap":8078745577},{"date":"2021-07-09","current":110.624168,"twenty":10.909728,"median":17.800494,"eighty":28.094741,"marketCap":8175126010},{"date":"2021-07-16","current":109.669307,"twenty":10.909728,"median":17.858714,"eighty":28.147385,"marketCap":8104561764},{"date":"2021-07-23","current":112.464023,"twenty":10.909728,"median":17.895254,"eighty":28.273886,"marketCap":8311091263},{"date":"2021-07-30","current":114.012761,"twenty":10.909728,"median":17.961478,"eighty":28.484828,"marketCap":8425543027},{"date":"2021-08-06","current":129.680663,"twenty":10.992528,"median":18.05485,"eighty":28.590528,"marketCap":8416275000},{"date":"2021-08-13","current":130.317458,"twenty":11.908323,"median":18.129025,"eighty":29.304513,"marketCap":8457603000},{"date":"2021-08-20","current":124.413837,"twenty":12.081322,"median":18.279305,"eighty":36.172726,"marketCap":8074458000},{"date":"2021-08-27","current":130.158259,"twenty":12.269852,"median":18.383346,"eighty":37.585545,"marketCap":8447271000},{"date":"2021-09-03","current":124.639368,"twenty":12.470247,"median":18.493625,"eighty":37.946982,"marketCap":8089095000},{"date":"2021-09-10","current":119.001079,"twenty":12.690576,"median":18.640556,"eighty":38.124897,"marketCap":7723170000},{"date":"2021-09-17","current":115.963035,"twenty":12.895567,"median":18.783612,"eighty":38.395217,"marketCap":7526001000},{"date":"2021-09-24","current":113.774052,"twenty":13.19202,"median":18.931002,"eighty":38.888953,"marketCap":7383936000},{"date":"2021-10-01","current":115.259908,"twenty":13.428823,"median":19.214087,"eighty":39.112479,"marketCap":7480368000},{"date":"2021-10-08","current":120.062404,"twenty":13.794237,"median":19.422181,"eighty":39.417939,"marketCap":7792050000},{"date":"2021-10-15","current":124.718968,"twenty":14.044522,"median":19.477563,"eighty":39.734486,"marketCap":8094261000},{"date":"2021-10-22","current":125.090431,"twenty":14.203499,"median":19.523623,"eighty":40.080877,"marketCap":8118369000},{"date":"2021-10-29","current":124.798567,"twenty":14.425812,"median":19.584723,"eighty":40.24573,"marketCap":8099427000},{"date":"2021-11-05","current":44.699357,"twenty":14.518586,"median":19.660032,"eighty":40.594022,"marketCap":8904112000},{"date":"2021-11-12","current":44.566145,"twenty":14.590371,"median":19.719712,"eighty":40.772986,"marketCap":8877576000},{"date":"2021-11-19","current":44.712249,"twenty":14.664702,"median":19.83907,"eighty":41.209216,"marketCap":8906680000},{"date":"2021-11-26","current":42.550763,"twenty":14.700597,"median":19.8949,"eighty":41.526679,"marketCap":8476112000},{"date":"2021-12-03","current":41.14988,"twenty":14.736559,"median":19.983221,"eighty":41.659541,"marketCap":8197056000},{"date":"2021-12-10","current":43.388715,"twenty":14.848889,"median":20.107627,"eighty":42.013653,"marketCap":8643032000},{"date":"2021-12-17","current":42.017912,"twenty":14.888035,"median":20.244036,"eighty":42.530665,"marketCap":8369968000},{"date":"2021-12-23","current":43.143775,"twenty":14.928456,"median":20.366557,"eighty":42.590297,"marketCap":8594240000},{"date":"2021-12-31","current":43.912972,"twenty":14.978377,"median":20.52396,"eighty":42.716518,"marketCap":8747464000},{"date":"2022-01-07","current":43.216827,"twenty":15.014369,"median":20.583639,"eighty":42.809409,"marketCap":8608792000},{"date":"2022-01-14","current":42.778514,"twenty":15.09084,"median":20.642188,"eighty":42.833518,"marketCap":8521480000},{"date":"2022-01-21","current":40.316225,"twenty":15.134841,"median":20.695232,"eighty":42.833518,"marketCap":8030992000},{"date":"2022-01-28","current":38.93253,"twenty":15.168148,"median":20.760517,"eighty":42.831799,"marketCap":7755360000},{"date":"2022-02-04","current":39.534137,"twenty":15.233454,"median":20.852196,"eighty":42.831799,"marketCap":7875200000},{"date":"2022-02-11","current":23.528043,"twenty":15.286862,"median":20.914716,"eighty":42.831799,"marketCap":7441920000},{"date":"2022-02-18","current":23.562001,"twenty":15.336296,"median":21.021034,"eighty":42.831799,"marketCap":7452661000},{"date":"2022-02-25","current":23.872134,"twenty":15.345418,"median":21.060963,"eighty":42.831799,"marketCap":7550756000},{"date":"2022-03-04","current":21.54479,"twenty":15.366895,"median":21.262392,"eighty":42.831799,"marketCap":6814617000},{"date":"2022-03-11","current":20.576636,"twenty":15.429502,"median":21.297173,"eighty":42.831799,"marketCap":6508390000},{"date":"2022-03-18","current":21.943917,"twenty":15.587108,"median":21.457724,"eighty":42.831799,"marketCap":6940861000},{"date":"2022-03-25","current":20.973067,"twenty":15.710319,"median":21.475183,"eighty":42.831799,"marketCap":6633781000},{"date":"2022-04-01","current":20.509216,"twenty":15.808632,"median":21.485477,"eighty":42.831799,"marketCap":6487065000},{"date":"2022-04-08","current":19.00238,"twenty":15.841022,"median":21.485477,"eighty":42.831799,"marketCap":6010452742},{"date":"2022-04-14","current":19.13217,"twenty":15.92508,"median":21.485477,"eighty":42.831799,"marketCap":6051505458},{"date":"2022-04-22","current":19.232824,"twenty":15.971288,"median":21.485477,"eighty":42.831799,"marketCap":6083342258},{"date":"2022-04-29","current":18.599765,"twenty":16.01115,"median":21.485477,"eighty":42.831799,"marketCap":5883105541},{"date":"2022-05-06","current":19.630305,"twenty":16.057676,"median":21.485477,"eighty":42.831799,"marketCap":5985280000},{"date":"2022-05-13","current":19.857609,"twenty":16.119087,"median":21.485477,"eighty":42.831799,"marketCap":6054585000},{"date":"2022-05-20","current":18.907314,"twenty":16.154056,"median":21.485477,"eighty":42.831799,"marketCap":5764840000},{"date":"2022-05-27","current":19.989062,"twenty":16.319805,"median":21.485477,"eighty":42.831799,"marketCap":6094665000},{"date":"2022-06-03","current":20.380682,"twenty":16.364034,"median":21.485477,"eighty":42.831799,"marketCap":6214070000},{"date":"2022-06-10","current":19.296195,"twenty":16.394815,"median":21.485477,"eighty":42.831799,"marketCap":5883410000},{"date":"2022-06-17","current":17.617432,"twenty":16.449762,"median":21.485477,"eighty":42.831799,"marketCap":5371555000},{"date":"2022-06-24","current":19.049721,"twenty":16.468413,"median":21.490888,"eighty":42.833518,"marketCap":5808260000},{"date":"2022-07-01","current":18.485569,"twenty":16.521426,"median":21.490888,"eighty":42.833518,"marketCap":5636250000},{"date":"2022-07-08","current":18.570466,"twenty":16.54581,"median":21.490888,"eighty":42.833518,"marketCap":5662135000},{"date":"2022-07-15","current":18.329469,"twenty":16.60915,"median":21.490888,"eighty":42.833518,"marketCap":5588655000},{"date":"2022-07-22","current":19.320843,"twenty":16.638079,"median":21.490888,"eighty":42.833518,"marketCap":5890925000},{"date":"2022-07-29","current":20.547737,"twenty":16.668873,"median":21.490888,"eighty":42.833518,"marketCap":6265005000},{"date":"2022-08-05","current":19.034358,"twenty":16.72041,"median":21.490888,"eighty":42.833518,"marketCap":6481199000},{"date":"2022-08-12","current":20.195316,"twenty":16.796305,"median":21.490888,"eighty":42.833518,"marketCap":6876505000},{"date":"2022-08-19","current":19.624552,"twenty":16.854242,"median":21.490888,"eighty":42.833518,"marketCap":6682160000},{"date":"2022-08-26","current":18.249862,"twenty":16.895102,"median":21.490888,"eighty":42.833518,"marketCap":6214078000},{"date":"2022-09-02","current":17.482367,"twenty":16.926157,"median":21.490888,"eighty":42.833518,"marketCap":5952746000},{"date":"2022-09-09","current":18.385874,"twenty":16.957418,"median":21.490888,"eighty":42.833518,"marketCap":6260390000},{"date":"2022-09-16","current":17.125336,"twenty":16.995287,"median":21.490888,"eighty":42.833518,"marketCap":5831177000},{"date":"2022-09-23","current":16.248546,"twenty":17.00767,"median":21.490888,"eighty":42.833518,"marketCap":5532630000},{"date":"2022-09-30","current":15.869656,"twenty":17.00767,"median":21.490888,"eighty":42.833518,"marketCap":5403618000},{"date":"2022-10-07","current":16.872743,"twenty":17.052062,"median":21.490888,"eighty":42.833518,"marketCap":5745169000},{"date":"2022-10-14","current":16.306837,"twenty":17.03955,"median":21.490888,"eighty":42.833518,"marketCap":5552478000},{"date":"2022-10-21","current":17.215201,"twenty":16.997944,"median":21.490888,"eighty":42.833518,"marketCap":5861776000},{"date":"2022-10-28","current":18.694329,"twenty":16.997944,"median":21.490888,"eighty":42.833518,"marketCap":6365419000},{"date":"2022-11-04","current":17.596438,"twenty":16.987608,"median":21.470301,"eighty":42.833518,"marketCap":6253774000},{"date":"2022-11-11","current":19.220653,"twenty":16.987608,"median":21.286874,"eighty":42.833518,"marketCap":6831020000},{"date":"2022-11-18","current":19.613908,"twenty":16.987608,"median":21.10521,"eighty":42.833518,"marketCap":6970783000},{"date":"2022-11-25","current":19.68139,"twenty":16.987608,"median":21.055389,"eighty":42.833518,"marketCap":6994766000},{"date":"2022-12-02","current":19.720948,"twenty":16.987608,"median":21.004235,"eighty":42.833518,"marketCap":7008825000},{"date":"2022-12-09","current":18.757589,"twenty":16.987608,"median":20.913296,"eighty":42.833518,"marketCap":6666447000},{"date":"2022-12-16","current":17.924539,"twenty":16.987608,"median":20.870668,"eighty":42.833518,"marketCap":6370381000},{"date":"2022-12-23","current":18.613317,"twenty":16.987608,"median":20.78257,"eighty":42.833518,"marketCap":6615173000},{"date":"2022-12-30","current":18.871609,"twenty":16.987608,"median":20.706576,"eighty":42.833518,"marketCap":6706970000},{"date":"2023-01-06","current":19.839623,"twenty":16.987608,"median":20.695232,"eighty":42.833518,"marketCap":7051002000},{"date":"2023-01-13","current":20.512113,"twenty":16.987608,"median":20.660369,"eighty":42.833518,"marketCap":7290005000},{"date":"2023-01-20","current":20.03276,"twenty":16.987608,"median":20.6149,"eighty":42.833518,"marketCap":7119643000},{"date":"2023-01-27","current":21.235796,"twenty":16.987608,"median":20.613626,"eighty":42.833518,"marketCap":7547202000},{"date":"2023-02-03","current":21.501069,"twenty":16.987608,"median":20.613626,"eighty":42.833518,"marketCap":7641480000},{"date":"2023-02-10","current":20.503741,"twenty":16.987608,"median":20.594293,"eighty":42.833518,"marketCap":7524873000},{"date":"2023-02-17","current":21.224831,"twenty":16.987608,"median":20.594293,"eighty":42.833518,"marketCap":7789513000},{"date":"2023-02-24","current":20.237839,"twenty":16.987608,"median":20.576636,"eighty":42.833518,"marketCap":7427287000},{"date":"2023-03-03","current":21.143708,"twenty":16.987608,"median":20.563152,"eighty":42.833518,"marketCap":7759741000},{"date":"2023-03-10","current":19.485202,"twenty":16.987608,"median":20.547737,"eighty":42.833518,"marketCap":7151069000},{"date":"2023-03-17","current":17.849229,"twenty":16.987608,"median":20.509216,"eighty":42.833518,"marketCap":6550667000},{"date":"2023-03-24","current":18.182733,"twenty":16.987608,"median":20.481207,"eighty":42.833518,"marketCap":6673063000},{"date":"2023-03-31","current":19.472003,"twenty":16.987913,"median":20.415732,"eighty":42.831799,"marketCap":7146225200},{"date":"2023-04-06","current":18.341589,"twenty":16.987608,"median":20.384708,"eighty":42.833518,"marketCap":6731363227},{"date":"2023-04-14","current":18.842491,"twenty":16.987303,"median":20.286778,"eighty":42.835237,"marketCap":6915194281},{"date":"2023-04-21","current":18.955307,"twenty":16.987303,"median":20.244036,"eighty":42.835237,"marketCap":6956597671},{"date":"2023-04-28","current":18.840235,"twenty":16.987303,"median":20.19855,"eighty":42.835237,"marketCap":6914366213},{"date":"2023-05-05","current":17.397447,"twenty":16.987303,"median":20.134588,"eighty":42.835237,"marketCap":6823278754},{"date":"2023-05-12","current":17.158613,"twenty":16.987303,"median":20.092886,"eighty":42.835237,"marketCap":6729608000},{"date":"2023-05-17","current":16.998939,"twenty":16.987303,"median":20.039643,"eighty":42.835237,"marketCap":6666984000},{"date":"2023-05-25","current":16.614462,"twenty":16.968614,"median":19.997502,"eighty":42.849386,"marketCap":6516192000},{"date":"2023-06-02","current":16.490505,"twenty":16.945108,"median":19.953392,"eighty":42.860096,"marketCap":6467576000},{"date":"2023-06-09","current":18.175482,"twenty":16.945108,"median":19.8949,"eighty":42.860096,"marketCap":7128424000},{"date":"2023-06-15","current":18.389781,"twenty":16.943815,"median":19.856121,"eighty":42.870807,"marketCap":7212472000},{"date":"2023-06-23","current":18.34566,"twenty":16.941231,"median":19.839623,"eighty":42.892228,"marketCap":7195168000},{"date":"2023-06-30","current":19.404549,"twenty":16.940163,"median":19.804237,"eighty":42.911254,"marketCap":7610464000},{"date":"2023-07-07","current":19.417155,"twenty":16.940163,"median":19.743538,"eighty":42.911254,"marketCap":7615408000},{"date":"2023-07-14","current":20.581091,"twenty":16.940163,"median":19.725724,"eighty":42.911254,"marketCap":8071904000},{"date":"2023-07-21","current":20.614707,"twenty":16.940163,"median":19.725724,"eighty":42.911254,"marketCap":8085088000},{"date":"2023-07-28","current":20.410913,"twenty":16.940163,"median":19.725724,"eighty":42.911254,"marketCap":8005160000},{"date":"2023-08-04","current":19.626489,"twenty":16.940163,"median":19.718909,"eighty":42.911254,"marketCap":8356959000},{"date":"2023-08-11","current":18.98442,"twenty":16.940163,"median":19.694637,"eighty":42.911254,"marketCap":8083566000},{"date":"2023-08-18","current":18.404051,"twenty":16.940163,"median":19.676395,"eighty":42.911254,"marketCap":7836445000},{"date":"2023-08-25","current":18.708697,"twenty":16.940163,"median":19.633035,"eighty":42.911254,"marketCap":7966163000},{"date":"2023-09-01","current":19.720968,"twenty":16.940163,"median":19.625521,"eighty":42.911254,"marketCap":8397188000},{"date":"2023-09-08","current":19.327628,"twenty":16.940163,"median":19.588986,"eighty":42.911254,"marketCap":8229704000},{"date":"2023-09-15","current":19.393185,"twenty":16.940163,"median":19.575353,"eighty":42.911254,"marketCap":8257618000},{"date":"2023-09-22","current":18.340423,"twenty":16.940163,"median":19.542094,"eighty":42.911254,"marketCap":7809352000},{"date":"2023-09-29","current":19.057689,"twenty":16.940163,"median":19.509413,"eighty":42.911254,"marketCap":8114764000},{"date":"2023-10-06","current":18.602649,"twenty":16.940163,"median":19.495171,"eighty":42.911254,"marketCap":7921008000},{"date":"2023-10-13","current":19.337269,"twenty":16.940163,"median":19.481118,"eighty":42.911254,"marketCap":8233809000},{"date":"2023-10-20","current":18.234375,"twenty":16.940163,"median":19.459037,"eighty":42.911254,"marketCap":7764197000},{"date":"2023-10-23","current":18.330782,"twenty":16.940163,"median":19.45322,"eighty":42.911254,"marketCap":7805247000},{"date":"2023-11-03","current":18.862957,"twenty":16.935891,"median":19.423169,"eighty":42.987358,"marketCap":8190296000},{"date":"2023-11-10","current":19.010442,"twenty":16.935891,"median":19.40544,"eighty":42.987358,"marketCap":8254334000},{"date":"2023-11-17","current":20.38886,"twenty":16.935891,"median":19.40544,"eighty":42.987358,"marketCap":8852843000},{"date":"2023-11-24","current":20.70652,"twenty":16.935891,"median":19.40544,"eighty":42.987358,"marketCap":8990771000},{"date":"2023-12-01","current":20.472057,"twenty":16.935891,"median":19.40544,"eighty":42.987358,"marketCap":8888967000},{"date":"2023-12-08","current":21.192464,"twenty":16.936959,"median":19.406332,"eighty":42.968332,"marketCap":9201768000},{"date":"2023-12-15","current":21.986614,"twenty":16.935891,"median":19.40544,"eighty":42.987358,"marketCap":9546588000},{"date":"2023-12-22","current":22.251331,"twenty":16.935891,"median":19.408774,"eighty":42.987358,"marketCap":9661528000},{"date":"2023-12-29","current":22.742948,"twenty":16.934469,"median":19.417155,"eighty":42.991835,"marketCap":9874988000},{"date":"2024-01-05","current":21.665173,"twenty":16.933047,"median":19.420656,"eighty":42.996311,"marketCap":9407018000},{"date":"2024-01-12","current":22.185152,"twenty":16.933047,"median":19.420656,"eighty":42.996311,"marketCap":9632793000},{"date":"2024-01-19","current":22.412052,"twenty":16.931624,"median":19.417155,"eighty":43.000788,"marketCap":9731313000},{"date":"2024-01-26","current":22.70324,"twenty":16.933047,"median":19.420656,"eighty":42.996311,"marketCap":9857747000},{"date":"2024-02-02","current":23.461465,"twenty":16.933047,"median":19.420656,"eighty":42.996311,"marketCap":10186968000},{"date":"2024-02-09","current":23.968,"twenty":16.933047,"median":19.420656,"eighty":42.996311,"marketCap":9838864000},{"date":"2024-02-16","current":24.984,"twenty":16.933047,"median":19.420656,"eighty":42.996311,"marketCap":10255932000},{"date":"2024-02-23","current":25.04,"twenty":16.939095,"median":19.425578,"eighty":42.996311,"marketCap":10278920000},{"date":"2024-03-01","current":25.228,"twenty":16.965456,"median":19.441388,"eighty":42.991835,"marketCap":10356094000},{"date":"2024-03-08","current":25.582,"twenty":16.996795,"median":19.472003,"eighty":42.991835,"marketCap":10501411000},{"date":"2024-03-15","current":25.38,"twenty":17.054431,"median":19.482285,"eighty":42.991835,"marketCap":10418490000},{"date":"2024-03-22","current":26.878,"twenty":17.10385,"median":19.504329,"eighty":42.991835,"marketCap":11033419000},{"date":"2024-03-28","current":27.37,"twenty":17.124929,"median":19.515097,"eighty":42.991835,"marketCap":11235385000},{"date":"2024-04-05","current":26.363357,"twenty":17.159049,"median":19.563994,"eighty":42.996311,"marketCap":10822158095},{"date":"2024-04-12","current":26.227092,"twenty":17.205781,"median":19.579004,"eighty":42.996311,"marketCap":10766221127},{"date":"2024-04-19","current":25.078855,"twenty":17.257231,"median":19.61923,"eighty":42.996311,"marketCap":10294869912},{"date":"2024-04-26","current":26.080807,"twenty":17.277298,"median":19.634456,"eighty":42.991835,"marketCap":10706171147},{"date":"2024-05-03","current":24.3073,"twenty":17.316319,"median":19.6714,"eighty":42.991835,"marketCap":10245527000},{"date":"2024-05-10","current":26.915907,"twenty":17.316319,"median":19.693713,"eighty":42.991835,"marketCap":11345055000},{"date":"2024-05-17","current":27.040871,"twenty":17.337235,"median":19.720948,"eighty":42.991835,"marketCap":11397727000},{"date":"2024-05-24","current":26.658171,"twenty":17.3579,"median":19.770865,"eighty":42.991835,"marketCap":11236419000},{"date":"2024-05-31","current":25.664323,"twenty":17.40069,"median":19.830544,"eighty":42.991835,"marketCap":10817512000},{"date":"2024-06-07","current":25.053174,"twenty":17.419219,"median":19.846604,"eighty":42.991835,"marketCap":10559913000},{"date":"2024-06-14","current":25.346057,"twenty":17.419219,"median":19.866812,"eighty":42.996311,"marketCap":10683363000},{"date":"2024-06-21","current":25.367535,"twenty":17.419219,"median":19.938136,"eighty":43.000788,"marketCap":10692416000},{"date":"2024-06-28","current":24.904781,"twenty":17.415675,"median":19.979477,"eighty":43.027648,"marketCap":10497365000},{"date":"2024-07-05","current":24.953594,"twenty":17.415675,"median":20.032539,"eighty":43.027648,"marketCap":10517940000},{"date":"2024-07-12","current":25.822479,"twenty":17.415675,"median":20.092886,"eighty":43.027648,"marketCap":10884175000},{"date":"2024-07-15","current":26.35162,"twenty":17.415675,"median":20.107627,"eighty":43.027648,"marketCap":11107208000},{"date":"2024-08-02","current":26.298899,"twenty":17.372647,"median":20.201785,"eighty":43.1369,"marketCap":11374274000},{"date":"2024-08-09","current":25.097484,"twenty":17.425912,"median":20.242615,"eighty":43.1369,"marketCap":10854662000},{"date":"2024-08-16","current":25.756751,"twenty":17.470199,"median":20.282684,"eighty":43.1369,"marketCap":11139795000},{"date":"2024-08-23","current":25.486622,"twenty":17.564048,"median":20.305663,"eighty":43.1369,"marketCap":11022964000},{"date":"2024-08-30","current":25.973988,"twenty":17.597954,"median":20.380682,"eighty":43.1369,"marketCap":11233750000},{"date":"2024-09-06","current":24.714014,"twenty":17.616246,"median":20.405877,"eighty":43.1369,"marketCap":10688811000},{"date":"2024-09-13","current":25.216492,"twenty":17.627965,"median":20.43424,"eighty":43.1369,"marketCap":10906133000},{"date":"2024-09-20","current":27.721329,"twenty":17.627965,"median":20.474157,"eighty":43.1369,"marketCap":11989475000},{"date":"2024-09-27","current":28.439156,"twenty":17.679032,"median":20.501225,"eighty":43.1369,"marketCap":12299935000},{"date":"2024-10-04","current":27.68166,"twenty":17.764761,"median":20.544998,"eighty":43.1369,"marketCap":11972318000},{"date":"2024-10-11","current":28.140691,"twenty":17.826043,"median":20.563746,"eighty":43.1369,"marketCap":12170849000},{"date":"2024-10-18","current":28.312592,"twenty":17.888802,"median":20.583639,"eighty":43.1369,"marketCap":12245196000},{"date":"2024-10-25","current":27.08662,"twenty":17.918603,"median":20.6149,"eighty":43.1369,"marketCap":11714963000},{"date":"2024-10-31","current":24.448312,"twenty":17.942906,"median":20.660369,"eighty":43.1369,"marketCap":11803645000},{"date":"2024-11-08","current":25.635025,"twenty":17.948902,"median":20.702813,"eighty":43.143775,"marketCap":12376590000},{"date":"2024-11-15","current":25.601263,"twenty":17.948902,"median":20.713166,"eighty":43.143775,"marketCap":12360290000},{"date":"2024-11-22","current":26.24273,"twenty":17.948902,"median":20.782305,"eighty":43.143775,"marketCap":12669990000},{"date":"2024-11-29","current":26.354143,"twenty":17.948902,"median":20.830683,"eighty":43.143775,"marketCap":12723780000},{"date":"2024-12-06","current":26.406473,"twenty":17.948902,"median":20.87078,"eighty":43.143775,"marketCap":12749045000},{"date":"2024-12-13","current":25.687355,"twenty":17.948902,"median":20.914716,"eighty":43.143775,"marketCap":12401855000},{"date":"2024-12-20","current":24.060056,"twenty":17.948902,"median":20.978392,"eighty":43.143775,"marketCap":11616195000},{"date":"2024-12-27","current":24.394294,"twenty":17.948902,"median":20.993976,"eighty":43.143775,"marketCap":11777565000},{"date":"2025-01-03","current":23.940203,"twenty":17.948902,"median":21.008675,"eighty":43.143775,"marketCap":11558330000},{"date":"2025-01-10","current":24.129267,"twenty":17.947403,"median":21.080613,"eighty":43.144947,"marketCap":11649610000},{"date":"2025-01-17","current":25.174182,"twenty":17.947403,"median":21.159482,"eighty":43.144947,"marketCap":12154095000},{"date":"2025-01-24","current":25.861226,"twenty":17.947403,"median":21.235796,"eighty":43.144947,"marketCap":12485800000},{"date":"2025-01-31","current":25.638401,"twenty":17.947403,"median":21.312586,"eighty":43.144947,"marketCap":12378220000},{"date":"2025-02-07","current":23.023923,"twenty":17.947403,"median":21.501069,"eighty":43.144947,"marketCap":11933299101},{"date":"2025-02-14","current":23.269276,"twenty":17.947403,"median":21.582513,"eighty":43.144947,"marketCap":12060465893},{"date":"2025-02-21","current":23.25984,"twenty":17.947403,"median":21.720007,"eighty":43.144947,"marketCap":12055574862},{"date":"2025-02-28","current":22.121147,"twenty":17.997291,"median":21.943917,"eighty":43.144947,"marketCap":11465390523},{"date":"2025-03-07","current":21.625721,"twenty":18.102725,"median":21.951634,"eighty":43.14612,"marketCap":11208611425},{"date":"2025-03-14","current":20.435127,"twenty":18.191168,"median":21.951634,"eighty":43.14612,"marketCap":10591526417},{"date":"2025-03-21","current":21.2514,"twenty":18.209046,"median":21.951634,"eighty":43.14612,"marketCap":11014600550},{"date":"2025-03-28","current":21.084685,"twenty":18.267172,"median":21.970542,"eighty":43.14612,"marketCap":10928192346},{"date":"2025-04-04","current":18.804155,"twenty":18.330257,"median":21.970542,"eighty":43.14612,"marketCap":9746193323},{"date":"2025-04-11","current":19.233523,"twenty":18.338495,"median":21.95447,"eighty":43.144947,"marketCap":9968735208},{"date":"2025-04-17","current":19.939702,"twenty":18.353993,"median":21.95447,"eighty":43.144947,"marketCap":10334747319},{"date":"2025-04-25","current":21.631822,"twenty":18.41177,"median":21.970542,"eighty":43.14612,"marketCap":11211773333},{"date":"2025-05-02","current":21.074247,"twenty":18.442542,"median":21.970542,"eighty":43.14612,"marketCap":10857452000},{"date":"2025-05-09","current":21.911351,"twenty":18.479248,"median":21.970542,"eighty":43.14612,"marketCap":11288728000},{"date":"2025-05-16","current":22.940928,"twenty":18.526289,"median":22.103846,"eighty":43.14612,"marketCap":11819166000},{"date":"2025-05-23","current":22.647636,"twenty":18.565558,"median":22.198388,"eighty":43.14612,"marketCap":11668062000},{"date":"2025-05-30","current":23.072298,"twenty":18.587093,"median":22.278748,"eighty":43.14612,"marketCap":11886848000},{"date":"2025-06-06","current":22.885936,"twenty":18.630962,"median":22.509501,"eighty":43.14612,"marketCap":11790834000},{"date":"2025-06-13","current":23.241858,"twenty":18.680557,"median":22.661331,"eighty":43.14612,"marketCap":11974205000},{"date":"2025-06-20","current":23.014251,"twenty":18.708498,"median":22.769841,"eighty":43.147292,"marketCap":11856942000},{"date":"2025-06-27","current":24.068269,"twenty":18.723382,"median":22.858439,"eighty":43.147292,"marketCap":12399972000},{"date":"2025-07-03","current":24.613608,"twenty":18.759059,"median":22.917464,"eighty":43.147292,"marketCap":12680931000},{"date":"2025-07-11","current":24.068269,"twenty":18.798507,"median":22.972021,"eighty":43.147292,"marketCap":12399972000},{"date":"2025-07-16","current":23.819276,"twenty":18.834814,"median":22.99592,"eighty":43.147292,"marketCap":12271691000}],"updateTime":1752809407745}}}